/Investor DB

Woodford Investment Management — 2020 Investments

1 investments dated 2020 · listed companies and verified rows first · show all

Mereo BioPharma Groupmereobiopharma.cominNASDAQ: MREOJun 2020

Mereo BioPharma is a biopharmaceutical company publicly traded on Nasdaq under the ticker MREO.

BiotechHealthtechLondon, GB

John Richard(Head of Corporate Development and Co-Founder)inCharles Sermon(General Counsel and Co-Founder)Richard Jones(Chief Financial Officer)inJill Henrich(Senior Vice President)inDenise Scots-Knight(Chief Executive Officer)in

BoardDr. Deepa Pakianathan(Non-Executive Director)

Co-investorsCancer FocusPontifax Venture CapitalVivo Capital

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.